The mechanism by which HFS develops is not fully understood; it is possible that the drug interferes with pericyte‐mediated endothelial survival mechanisms, leading to damage to the capillary endothelium in the hands and feet (74) or the inhibition of KIT (strongly expressed in the ductal epithelium of eccrine glands) (75). This evidence concerns the gene KIT and Hand-foot syndrome.